Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M. Younossi, Victor Ankoma‐Sey, David Sheridan et al.|The Lancet|2019Cited by 1.2k
Current therapies and new developments in NASHJean‐François Dufour, Shira Zelber‐Sagi|Gut|2022Cited by 194
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Marco Enea et al.|Gut|2021Cited by 96
PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic PatientsNaomi F. Lange, Jean‐François Dufour|International Journal of Molecular Sciences|2022Cited by 76
Hint2, A Mitochondrial Apoptotic Sensitizer Down-Regulated in Hepatocellular CarcinomaJuliette Martin, Jean‐François Dufour|Gastroenterology|2006Cited by 65